Long-term disease-free survival after resection of hepatocellular carcinoma: Both tumor behavior and surgeon's performance are important determinants

Annals of Surgical Oncology

Volumn 10, Issue 8, 2003, Pages 834-836

  Poon, Ronnie Tung Ping ^a   Wong, John ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; DISEASE SEVERITY; EDITORIAL; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER METASTASIS; LIVER TRANSPLANTATION; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; PROBABILITY; PROGNOSIS; RECURRENT DISEASE; REDUCTION; SURGICAL TECHNIQUE; SURVIVAL RATE; TASK PERFORMANCE; CLINICAL COMPETENCE; DISEASE FREE SURVIVAL; LIVER TUMOR; NOTE; PATHOLOGY; RISK FACTOR;

CARCINOMA, HEPATOCELLULAR; CLINICAL COMPETENCE; DISEASE-FREE SURVIVAL; HUMANS; LIVER NEOPLASMS; PROGNOSIS; RISK FACTORS;

EID: 1542439936     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2003.08.908     Document Type: Editorial

References (17)

1. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999;19:271-85.
2. Poon RT, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000;232:10-24.
3. Farges O, Regimbeau JM, Belghiti J. Aggressive management of recurrence following surgical resection of hepatocellular carcinoma. Hepatogastroenterology 1998;45(Suppl 3):1275-80.
4. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999;229:216-22.
5. Wudel LJ Jr, Chapman WC. Indications and limitations of liver transplantation for hepatocellular carcinoma. Surg Oncol Clin N Am 2003;12:77-90.
6. Yeh CN, Lee WC, Chen MF, Tsay PK. Predictors of long-term disease-free survival after resection of hepatocellular carcinoma: two decades of experience at Chang Gung Memorial Hospital. Ann Surg Oncol 2003;10:916-21.
7. Matsumata T, Ikeda Y, Hayashi H, Kamakura T, Taketomi A, Sugimachi K. The association between transfusion and cancer-free survival after curative resection for hepatocellular carcinoma. Cancer 1993;72:1866-71.
8. Yamamoto J, Kosuge T, Takayama T, et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 1994;115:303-9.
9. Fan ST, Ng IO, Poon RT, Lo CM, Liu CL, Wong J. Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival. Arch Surg 1999;134:1124-30.
10. Poon RT, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001;234:63-70.
11. Fan ST, Lo CM, Liu CL, et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 1999;229:322-30.
12. Torzilli G, Makuuchi M, Inoue K, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 1999;134:984-92.
13. Fong Y, Sun RL, Jamagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999;229:790-9.
14. Liu CL, Fan ST, Lo CM, Ng IO, Poon RT, Wong J. Intraoperative iatrogenic rupture of hepatocellular carcinoma. World J Surg 2002; 26:348-52.
15. Liu CL, Fan ST, Lo CM, Poon RT, Wong J. Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg 2000;232:25-31.
16. Muto Y, Moriwaki H, Ninomiya M, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med 1996;334:1561-7.
17. Takayama T, Sekine T, Makuuchi M, et al. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 2000;356:802-7.